Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products
The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide.
Tilray Brands stock is trading lower on Monday, alongside other cannabis-related stocks, following President Donald Trump's announcement of new tariffs on imported goods from Canada, Mexico and China, set to take effect Tuesday.
A recently published JAMA study explored the effects of home marijuana smoking on children’s exposure to secondhand marijuana smoke (SHCS). Researchers in the U.S. used urinary biomarkers to assess the levels of delta 9 THC and its metabolites in kids, aiming to measure the extent of exposure and show the importance of preventive actions to protect their health.
ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is excited to announce the 20th anniversary of its Wake-n-Bake Coffee Oatmeal Imperial Stout seasonal beer and the annual Wake-n-Bake Off event on Sunday, January 26th, 2025, at the Terrapin taproom in Athens, GA.
Cannabis regulators in Illinois have expanded the list of qualifying conditions for medical marijuana for the first time since legalization in 2019, focusing specifically on women’s health issues.
Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions.
Shares of cannabis company Tilray Brands (NASDAQTLRY)
fell 13.5% in the morning session after the company reported underwhelming fourth quarter results. Its revenue and EBITDA missed significantly, and its gross margin fell short of Wall Street's estimates. Also, the company recorded significant operating losses and continued to burn cash. On the other hand, revenue guidance for 2025 came in ahead of expectations, though sales are partly benefiting from recent acquisitions following the company's expansion to the beverage market, which suggests organic growth is not as strong. Zooming out, we think this was a mixed quarter. The market seemed to focus on the negatives, and the stock traded down.
Cannabis company Tilray Brands (NASDAQTLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year on year to $211 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 8.2% above analysts’ estimates. Its non-GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates.
